Advertisement

Related Videos

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Opening Session Panel Discussion

Advertisement

Advertisement




Apr
28
Today In Oncology
RAS Inhibitor Daraxonrasib in Metastatic Pancreatic Cancer
Early-Onset Lung Cancer May Be Connected to Pesticide Contaminants
ACP Issues Controversial New Breast Cancer Screening Guidelines
Educational Disparities in Young-Onset Colorectal Cancer Mortality
Breast Cancer Clonal Hematopoiesis and Risk of Trastuzumab-Related Cardiotoxicity
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo